Approvals/CIMA-AEMPS/TAMSULOSINA AUROVITAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

TAMSULOSINA AUROVITAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d0669fac735e1e10
Drug Cima Aemps Name: TAMSULOSINA AUROVITAS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 85823
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2021-03-08
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

TAMSULOSINA HIDROCLORURO

0,4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 8, 2021

Approval ID

d0669fac735e1e10

Type

Standard